VALEANT PHARMACEUTICALS NORTH has a total of 25 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Poland and Czechia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are CERECOR INC, ELIAZ ISAAC and GLAXO WELLCOME LAB SA.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Syringes | |
#6 | Unspecified technologies | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rostock Angelika | 6 |
#2 | Tober Christine | 6 |
#3 | Bartsch Reni | 6 |
#4 | Rundfeldt Chris | 6 |
#5 | Hong Zhi | 5 |
#6 | Dost Rita | 5 |
#7 | Thiel Wilfried | 4 |
#8 | Kutscher Bernhard | 4 |
#9 | Tam Robert | 4 |
#10 | Rischer Matthias | 4 |
Publication | Filing date | Title |
---|---|---|
US2008045534A1 | Derivatives of 1,3-diamino benzene as potassium channel modulators | |
US7799832B2 | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains | |
US2004162528A1 | Drug delivery system for administering an adjustable preset dose | |
US2006183706A1 | 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents | |
US7638496B2 | Nucleoside analogs with carboxamidine modified monocyclic base |